Welcome to our dedicated page for NIGHTINGALE HEALTH OYJ news (Ticker: NHLTY), a resource for investors and traders seeking the latest updates and insights on NIGHTINGALE HEALTH OYJ stock.
Nightingale Health SP/ADR (NHLTY) provides U.S. investors with access to Nightingale Health Oyj through American Depositary Receipts traded on the OTCQX platform. The company states that it has developed the world’s most advanced health check, focused on detecting risk for multiple chronic diseases from a single blood sample and scaling this approach to entire populations.
This news page highlights announcements related to the NHLTY ADR program and Nightingale Health’s broader activities. Readers can find updates on the ADR structure itself, such as the appointment of Citi Issuer Services, acting through Citibank N.A., as depositary bank for the sponsored Level 1 ADR program. Coverage may also include statements from the company about its global ambitions, its focus on the U.S. healthcare market, and its efforts to expand access for U.S. investors.
Because Nightingale Health links its ADR program to its global growth strategy and to the importance of the U.S. as a healthcare market, news about NHLTY can offer context on how the company is positioning its health check solution internationally. Articles may discuss how the ADRs relate to the underlying ordinary shares listed on Nasdaq Helsinki under the symbol HEALTH FH and how Citi’s issuer services support cross-border capital market access.
Investors and observers who follow NHLTY news can use this page to monitor developments around the ADR program and Nightingale Health’s stated mission to build sustainable healthcare and reduce health inequalities. Returning to this page provides an organized view of company-related announcements and market-structure updates connected to the ADRs.
Citi has been appointed as the depositary bank for Nightingale Health OYJ's sponsored Level 1 American Depositary Receipt (ADR) program. The company's ADRs trade on the OTCQX platform under the symbol 'NHLTY', with each ADR representing one ordinary share. The underlying ordinary shares are listed on the Nasdaq Helsinki Stock Exchange under 'HEALTH FH'.
This strategic move aims to provide U.S. investors easier access to Nightingale Health's shares, aligning with the company's global expansion strategy, particularly in the U.S. healthcare market. The partnership leverages Citi's global network through its Issuer Services business, which operates depositary receipt programs across 65 markets.